VFO
PROK icon

Virtus Family Office’s ProKidney PROK Stock Holding History

Virtus Family Office’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.2K Hold
27,500
– – 0.04% 73
2025
Q4 		$61.6K Hold
27,500
– – 0.05% 64
2025
Q3 		$66.5K Hold
27,500
– – 0.06% 52
2025
Q2 		$16.3K Hold
27,500
– – 0.02% 43
2025
Q1 		$24.1K Buy
+27,500
New +$38.2K 0.03% 40
2024
Q4 		– Sell
-27,500
Closed -$52.8K – 46
2024
Q3 		$52.8K Buy
+27,500
New +$62.4K 0.07% 47

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Virtus Family Office's PROK Position: Q1 2026 in Review

Virtus Family Office held its ProKidney (PROK) position steady in Q1 2026 at 27,500 shares worth $49.2K. The position accounts for 0.04% of the portfolio, ranked #73.

Virtus Family Office first reported a position in PROK in Q3 2024 and has held it in 6 quarters since. The position peaked at $66.5K in Q3 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Virtus Family Office held 27,500 shares of ProKidney worth $49.2K as of Q1 2026.
  • Virtus Family Office left its ProKidney share count unchanged in Q1 2026.
  • ProKidney made up 0.04% of Virtus Family Office's portfolio in Q1 2026, its #73 holding.
  • Virtus Family Office first reported a position in ProKidney in Q3 2024 and has held it in 6 quarters since.
  • Virtus Family Office's ProKidney position peaked at $66.5K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Virtus Family Office's 13F filing for Q1 2026, filed 7 May 2026.